ArticleCurrent topics in medicinal chemistry2026

Leveraging Tubulin Isotype Structural Differences to Design Less Hematotoxic β5 Selective Covalent Inhibitors for NSCLC.

Sonia Kumari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.